Gregory Rossi

2.3k total citations
12 papers, 586 citations indexed

About

Gregory Rossi is a scholar working on Hematology, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, Gregory Rossi has authored 12 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 5 papers in Pediatrics, Perinatology and Child Health and 3 papers in Genetics. Recurrent topics in Gregory Rossi's work include Erythropoietin and Anemia Treatment (11 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Iron Metabolism and Disorders (4 papers). Gregory Rossi is often cited by papers focused on Erythropoietin and Anemia Treatment (11 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Iron Metabolism and Disorders (4 papers). Gregory Rossi collaborates with scholars based in United States, United Kingdom and Belgium. Gregory Rossi's co-authors include David I. Watson, Michael Hedenus, Kerry Taylor, Alan Colowick, Giovanni Martinelli, Jesús F. San Miguel, Albert Altés, Martin R. Schipperus, Andrew Belch and Timothy J. Littlewood and has published in prestigious journals such as Cancer, British Journal of Haematology and Expert Opinion on Biological Therapy.

In The Last Decade

Gregory Rossi

12 papers receiving 559 citations

Peers

Gregory Rossi

HEMAT

BIOCH

PPCH

ONCOL

GENET

E Sundal Belgium

Shari Lennon United States

Fernando Carrera Switzerland

T. Schulzki Switzerland

Michelle Brown United Kingdom

M Takada Japan

Oliver Ng United Kingdom

Simona Sestili France

R. A. de Vries Netherlands

F. Léger France

E Sundal Belgium

Gregory Rossi

234 ×0.5

HEMAT

68 ×0.4

BIOCH

42 ×0.3

PPCH

42 ×0.3

ONCOL

50 ×0.5

GENET

Citations per year, relative to Gregory Rossi Gregory Rossi (= 1×) peers E Sundal

Countries citing papers authored by Gregory Rossi

Since Specialization

Citations

This map shows the geographic impact of Gregory Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Rossi more than expected).

Fields of papers citing papers by Gregory Rossi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Rossi. The network helps show where Gregory Rossi may publish in the future.

Co-authorship network of co-authors of Gregory Rossi

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Rossi. A scholar is included among the top collaborators of Gregory Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Rossi. Gregory Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Lin, Pei‐Jung, Thomas W. Concannon, Dan Greenberg, et al.. (2013). Does framing of cancer survival affect perceived value of care? A willingness-to-pay survey of US residents. Expert Review of Pharmacoeconomics & Outcomes Research. 13(4). 513–522. 14 indexed citations

2.

Vadhan‐Raj, Saroj, B. Mirtsching, Veena Charu, et al.. (2006). Assessment of hematologic effects and fatigue in cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks.. PubMed. 1(2). 131–8. 56 indexed citations

3.

Hesketh, Paul J., Francis P. Arena, Dhimant Patel, et al.. (2004). A randomized controlled trial of darbepoetin alfa administered as a fixed or weight‐based dose using a front‐loading schedule in patients with anemia who have nonmyeloid malignancies. Cancer. 100(4). 859–868. 39 indexed citations

4.

Hedenus, Michael, Magnus Adriansson, Jesús F. San Miguel, et al.. (2003). Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double‐blind, placebo‐controlled study. British Journal of Haematology. 122(3). 394–403. 267 indexed citations

5.

Vansteenkiste, Johan, Gregory Rossi, & MaryAnn Foote. (2003). Darbepoetin alfa: a new approach to the treatment of chemotherapy-induced anaemia. Expert Opinion on Biological Therapy. 3(3). 501–508. 10 indexed citations

6.

Glaspy, John A., et al.. (2003). A randomized, active‐control, pilot trial of front‐loaded dosing regimens of darbepoetin‐alfa for the treatment of patients with anemia during chemotherapy for malignant disease. Cancer. 97(5). 1312–1320. 69 indexed citations

7.

Vansteenkiste, Johan, Gregory Rossi, & MaryAnn Foote. (2003). Darbepoetin alfa: a new approach to the treatment of chemotherapy-induced anaemia. Expert Opinion on Biological Therapy. 3(3). 501–508. 1 indexed citations

8.

Hedenus, Michael, Søren B. Hansen, Kerry Taylor, et al.. (2002). Randomized, dose‐finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies. British Journal of Haematology. 119(1). 79–86. 75 indexed citations

9.

Vansteenkiste, Johan, Erik Poulsen, Gregory Rossi, & John A. Glaspy. (2002). Darbepoetin alfa: impact on treatment for chemotherapy-induced anemia and considerations in special populations.. PubMed. 16(10 Suppl 11). 45–55. 11 indexed citations

10.

Mirtsching, B., Veena Charu, Saroj Vadhan‐Raj, et al.. (2002). Every-2-Week Darbepoetin Alfa Is Comparable to rHuEPO in Treating Chemotherapy-Induced Anemia. 10 indexed citations

11.

Mirtsching, B., Veena Charu, Saroj Vadhan‐Raj, et al.. (2002). Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis.. PubMed. 16(10 Suppl 11). 31–6. 16 indexed citations

12.

Jumbe, Nelson L. ‘Shasha’, et al.. (2002). Clinical trial simulation of a 200-microg fixed dose of darbepoetin alfa in chemotherapy-induced anemia.. PubMed. 16(10 Suppl 11). 37–44. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact